Breaking News Instant updates and real-time market news.

EXPR

Express

$7.40

0.04 (0.54%)

, SIG

Signet Jewelers

$47.91

-0.07 (-0.15%)

20:25
03/13/18
03/13
20:25
03/13/18
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Express (EXPR), consensus 32c... Signet Jewelers (SIG), consensus $4.25... Vera Bradley (VRA), consensus 32c... Voyager Therapeutics (VYGR), consensus (72c)... Arena Pharmaceuticals (ARNA), consensus (59c).

EXPR

Express

$7.40

0.04 (0.54%)

SIG

Signet Jewelers

$47.91

-0.07 (-0.15%)

VRA

Vera Bradley

$10.30

0.19 (1.88%)

VYGR

Voyager Therapeutics

$24.26

-0.02 (-0.08%)

ARNA

Arena Pharmaceuticals

$39.28

-0.92 (-2.29%)

  • 14

    Mar

  • 14

    Mar

  • 14

    Mar

  • 14

    Mar

  • 14

    Mar

  • 16

    Apr

  • 17

    Apr

EXPR Express
$7.40

0.04 (0.54%)

01/10/18
RHCO
01/10/18
NO CHANGE
Target $8
RHCO
Hold
Express price target lowered to $8 from $10 at SunTrust
SunTrust analyst Pamela Quintiliano lowered her price target on Express to $8 after the company lowered its Q4 EPS guidance and comps. The analyst says her subsequent conversation with the management also suggest that the company will remain challenged in the near term. Quintiliano keeps her Hold rating on Express, noting potential risks around product improvement plans and downside traffic issues.
06/14/17
MSCO
06/14/17
NO CHANGE
Target $7.5
MSCO
Equal Weight
Express price target cut to $7.50 from $10.50 at Morgan Stanley
Morgan Stanley analyst Jay Sole said Express' shift to online is proving "hugely disruptive" as comps have declined at least 8% in each of the past four quarters. The analyst sees risk that mall traffic declines faster than Express can optimize stores and now valuations the stock primarily on the online business. Sole lowered his FY17 earnings estimate to 40c from 65c and cut Express' price target to $7.50 and maintained an Equal Weight rating.
12/01/17
BMOC
12/01/17
NO CHANGE
Target $10
BMOC
Market Perform
Express price target raised to $10 from $7 at BMO Capital
BMO Capital analyst John Morris raised his price target on Express to $10 from $7 and kept his Market Perform rating after Q3 results. Morris says that while the reported EPS of 8c was in line, it included a 2c impact from hurricanes and thus could have been higher. Additionally, Morris notes the comps decline of 1% was better than the expected 2% drop. Morris says the 23% growth in e-commerce supported the better comps, but contends that the company needs to close some stores to offset the online revenue shift.
12/01/17
RHCO
12/01/17
NO CHANGE
Target $10
RHCO
Hold
Express price target raised to $10 from $6 at SunTrust
SunTrust analyst Pamela Quintiliano raised her price target on Express to $10 after the second consecutive quarter of encouraging results. Quintiliano says the company's products fit well into the current business attire and denim trends while lease renegotiations provide additional tailwinds for FY18. The analyst keeps her Hold rating on Express, saying stock has already moved up materially over the last few months and noting potential risks from a competitive holiday season.
SIG Signet Jewelers
$47.91

-0.07 (-0.15%)

03/12/18
JPMS
03/12/18
NO CHANGE
Target $52
JPMS
Neutral
Signet Jewelers price target lowered to $52 from $65 at JPMorgan
JPMorgan analyst Matthew Boss lowered his price target for Signet Jewelers to $52 and maintains a Neutral rating on the shares. After meeting with management, the analyst says transitions "take time."
01/12/18
RBCM
01/12/18
DOWNGRADE
Target $55
RBCM
Sector Perform
Signet Jewelers downgraded to Sector Perform at RBC Capital on soft comps
As reported earlier, RBC Capital analyst Brian Tunick downgraded Signet Jewelers to Sector Perform from Outperform and lowered his price target to $55 from $60. Tunick says the latest disappointing holiday season comps are another reminder that his expectations of smoother SSS recovery based on the company's leading market position did not pan out. The analyst notes he is now less confident of share gains in the near term, adding that the sale of the company's subprime book in the first half of this year "could add incremental noise".
01/12/18
RBCM
01/12/18
DOWNGRADE
RBCM
Sector Perform
Signet Jewelers downgraded to Sector Perform from Outperform at RBC Capital
01/11/18
WELS
01/11/18
NO CHANGE
Target $52
WELS
Market Perform
Signet Jewelers price target lowered to $52 from $60 at Wells Fargo
Wells Fargo analyst Ike Boruchow lowered his price target for Signet Jewelers to $52 from $60 to reflect tax reform. The analyst reiterates a Market Perform rating on the shares.
VRA Vera Bradley
$10.30

0.19 (1.88%)

VYGR Voyager Therapeutics
$24.26

-0.02 (-0.08%)

03/12/18
03/12/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ranger Energy (RNGR) downgraded to Market Perform from Outperform at Wells Fargo with analyst Judson Bailey saying the growth and margin improvement story he originally forecasted has come in "well below expectations along with disappointing free cash flow." 2. Voyager Therapeutics (VYGR) was downgraded to In Line from Outperform at Evercore ISI and to Neutral from Outperform at Wedbush. 3. HubSpot (HUBS) downgraded to In Line from Outperform at Evercore ISI with analyst Kirk Materne saying he is taking a "few chips off the table" and sees more balanced risk/reward at current levels. 4. XL Group (XL) downgraded to Market Perform from Outperform at JMP Securities with analyst Matthew Carletti saying that he sees low odds of a superior offer following the company's announcement of a deal to be acquired by AXA (AXAHY) for $57.60 per share in cash. 5. Blackbaud (BLKB) downgraded to Underperform from In Line at Evercore ISI with analyst Kirk Materne saying Blackbaud's valuation reflects the current cloud transition and lower tax rate and is full relative to the company's TTM organic growth rate. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/12/18
EVER
03/12/18
DOWNGRADE
EVER
In Line
Voyager Therapeutics downgraded to In Line from Outperform at Evercore ISI
03/12/18
WEDB
03/12/18
DOWNGRADE
WEDB
Neutral
Voyager Therapeutics downgraded to Neutral from Outperform at Wedbush
03/12/18
03/12/18
DOWNGRADE
Target $29

Neutral
Voyager downgraded to Neutral after Parkinson's drug data at Wedbush
As previously reported, Wedbush analyst David Nierengarten downgraded Voyager Therapeutics to Neutral from Outperform, stating that data from its Phase 1 study of VY-AADC were "on the whole positive," though inconsistencies in dose response and variability in L-dopa usage "complicates" the story and raise questions on activity that could complicate the upcoming Phase 2/3 trial. However, Nierengarten raised his price target on Voyager shares to $29 from $22.
ARNA Arena Pharmaceuticals
$39.28

-0.92 (-2.29%)

02/27/18
SBSH
02/27/18
NO CHANGE
Target $55
SBSH
Buy
Arena Pharmaceuticals price target raised to $55 from $37 at Citi
Citi analyst Joel Beatty raised his price target for Arena Pharmaceuticals to $55 to reflect increased value expectations for etrasimod. The analyst now sees a 60% probability of approval in ulcerative colitis and he also added sales estimates for Crohn's disease. He sees $6-$12 of share upside and $18% of potential downside for the Phase II data for etrasimod in Q1. Beatty keeps a Buy rating on Arena shares.
02/20/18
JMPS
02/20/18
NO CHANGE
Target $63
JMPS
Outperform
Arena Pharmaceuticals price target raised to $63 from $36 at JMP Securities
JMP Securities analyst Jason Butler raised his price target on Arena Pharmaceuticals to $63 from $36, stating that he has high conviction in the potential for the company's Phase 2 trial of etrasimod in ulcerative colitis to show success when top-line results are reported next month. He has raised his probability of success for the program to 50% from 25% previously and increased his estimate of peak sales to $4B-$5B from about $3B. Butler keeps an Outperform rating on Arena shares.
01/18/18
01/18/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Caterpillar (CAT) initiated with a Buy at Berenberg. 2. Rosehill Resources (ROSE) initiated with an Outperform at Northland. 3. Arena Pharmaceuticals (ARNA) initiated with an Outperform at Credit Suisse. 4. Electronic Arts (EA) was initiated with an Outperform at Bernstein, while Activision Blizzard (ATVI) was initiated with a Market Perform. 5. Brookfield Business Partners (BBU) initiated with a Sector Perform at RBC Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/17/18
FBCO
01/17/18
INITIATION
Target $44
FBCO
Outperform
Arena Pharmaceuticals initiated with an Outperform at Credit Suisse
Credit Suisse analyst Martin Auster started Arena Pharmaceuticals with an Outperform rating and $44 price target. The analyst sees a "catalyst-rich" 2018 for the company, starting with proof-of-concept data for etrasimod in ulcerative colitis in Q1. He also believes ralinepag in pulmonary arterial hypertension has the potential to be best-in-class.

TODAY'S FREE FLY STORIES

IGC

India Globalization Capital

$1.94

-0.06 (-3.00%)

10:57
03/22/19
03/22
10:57
03/22/19
10:57
Hot Stocks
India Globalization Capital launches new website to sell bulk CBD products »

India Globalization…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVSI

CV Sciences

$0.00

(0.00%)

, CVS

CVS Health

$56.62

-0.78 (-1.36%)

10:55
03/22/19
03/22
10:55
03/22/19
10:55
Hot Stocks
CV Sciences strength attributed to reports of products seen at major retailers »

Shares of CV Sciences…

CVSI

CV Sciences

$0.00

(0.00%)

CVS

CVS Health

$56.62

-0.78 (-1.36%)

CURLF

Curaleaf Holdings

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

NOK

Nokia

$5.77

-0.49 (-7.83%)

10:50
03/22/19
03/22
10:50
03/22/19
10:50
Hot Stocks
Nokia says investigation 'not expected to have a material impact' »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

AES

AES Corp.

$18.28

-0.01 (-0.05%)

10:50
03/22/19
03/22
10:50
03/22/19
10:50
Options
AES Corp attracts a put buyer as shares reach 52-week highs »

AES Corp attracts a put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

ICE

IntercontinentalExchange

$72.88

-0.48 (-0.65%)

, MSFT

Microsoft

$118.88

-1.77 (-1.47%)

10:47
03/22/19
03/22
10:47
03/22/19
10:47
Periodicals
ICE's Bakkt crypto subsidary currently valued at around $740M, The Block reports »

Intercontinental…

ICE

IntercontinentalExchange

$72.88

-0.48 (-0.65%)

MSFT

Microsoft

$118.88

-1.77 (-1.47%)

SBUX

Starbucks

$72.09

-0.16 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 02

    May

  • 17

    May

  • 28

    May

CRZBY

Commerzbank

$0.00

(0.00%)

, DB

Deutsche Bank

$8.25

-0.185 (-2.19%)

10:45
03/22/19
03/22
10:45
03/22/19
10:45
Periodicals
Commerzbank CEO pledges quick decision on merger talks, Reuters says »

Commerzbank (CRZBY) CEO…

CRZBY

Commerzbank

$0.00

(0.00%)

DB

Deutsche Bank

$8.25

-0.185 (-2.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMTD

TD Ameritrade

$50.00

-2.07 (-3.98%)

10:40
03/22/19
03/22
10:40
03/22/19
10:40
Options
TD Ameritrade attracts a put spread as shares extend losses »

TD Ameritrade attracts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

SO

Southern Company

$52.00

0.45 (0.87%)

10:38
03/22/19
03/22
10:38
03/22/19
10:38
Hot Stocks
Southern Company announces closing of $1.67B in loan guarantees for Vogtle units »

Southern Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
03/22/19
03/22
10:35
03/22/19
10:35
General news
reasury Action: yields plumbed lows »

Treasury Action: yields…

DISCB

Discovery Inc.

$31.55

(0.00%)

10:34
03/22/19
03/22
10:34
03/22/19
10:34
Hot Stocks
Breaking Hot Stocks news story on Discovery Inc. »

Discovery Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

BMY

Bristol-Myers

$48.65

-0.27 (-0.55%)

, CELG

Celgene

$88.99

-0.63 (-0.70%)

10:33
03/22/19
03/22
10:33
03/22/19
10:33
Hot Stocks
Starboard is not short shares of Celgene, Smith says »

Starboard Value's…

BMY

Bristol-Myers

$48.65

-0.27 (-0.55%)

CELG

Celgene

$88.99

-0.63 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 12

    Apr

  • 12

    Apr

  • 25

    Apr

  • 18

    May

  • 20

    May

  • 28

    May

  • 27

    Jun

  • 03

    Sep

CELG

Celgene

$89.01

-0.61 (-0.68%)

, BMY

Bristol-Myers

$48.61

-0.31 (-0.63%)

10:32
03/22/19
03/22
10:32
03/22/19
10:32
Hot Stocks
Smith says Bristol-Myers bid values Celgene for 10 upcoming blockbusters »

Starboard Value's…

CELG

Celgene

$89.01

-0.61 (-0.68%)

BMY

Bristol-Myers

$48.61

-0.31 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 12

    Apr

  • 12

    Apr

  • 25

    Apr

  • 18

    May

  • 20

    May

  • 28

    May

  • 27

    Jun

  • 03

    Sep

CELG

Celgene

$89.10

-0.52 (-0.58%)

, BMY

Bristol-Myers

$48.66

-0.26 (-0.53%)

10:30
03/22/19
03/22
10:30
03/22/19
10:30
Hot Stocks
Starboard's Smith says Bristol-Myers does not need to do any deal »

Starboard Value's…

CELG

Celgene

$89.10

-0.52 (-0.58%)

BMY

Bristol-Myers

$48.66

-0.26 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 12

    Apr

  • 12

    Apr

  • 25

    Apr

  • 18

    May

  • 20

    May

  • 28

    May

  • 27

    Jun

  • 03

    Sep

FITB

Fifth Third

$24.88

-0.55 (-2.16%)

10:30
03/22/19
03/22
10:30
03/22/19
10:30
Options
Heavy call volume in Fifth Third Bank »

Heavy call volume in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 23

    Apr

DISCB

Discovery Inc.

$31.55

(0.00%)

10:29
03/22/19
03/22
10:29
03/22/19
10:29
Hot Stocks
Breaking Hot Stocks news story on Discovery Inc. »

Discovery Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

DHI

D.R. Horton

$40.93

0.4 (0.99%)

10:25
03/22/19
03/22
10:25
03/22/19
10:25
Options
D R Horton call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

10:25
03/22/19
03/22
10:25
03/22/19
10:25
General news
U.S. Data Slate - Week of March 25: »

U.S. Data Slate - Week of…

TRCH

Torchlight Energy Resources

$1.64

0.01 (0.61%)

10:25
03/22/19
03/22
10:25
03/22/19
10:25
Conference/Events
Torchlight Energy Resources to hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

INGN

Inogen

$92.59

-2.15 (-2.27%)

10:25
03/22/19
03/22
10:25
03/22/19
10:25
Conference/Events
Inogen participates in a conference call with JPMorgan »

Medical Supplies &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 10

    Apr

  • 12

    Jun

10:25
03/22/19
03/22
10:25
03/22/19
10:25
Conference/Events
Cowen Washington policy strategist to hold an analyst/industry conference call »

Washington Strategist…

LOV

Spark Networks

$12.78

1.49 (13.20%)

10:25
03/22/19
03/22
10:25
03/22/19
10:25
Conference/Events
Spark Networks to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

UTX

United Technologies

$125.73

-1.16 (-0.91%)

10:23
03/22/19
03/22
10:23
03/22/19
10:23
Hot Stocks
NORESCO announces $86.8M ESPC to enhance energy security for Navy Region Japan »

NORESCO is implementing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:20
03/22/19
03/22
10:20
03/22/19
10:20
General news
FX Action: The dollar »

FX Action: The dollar was…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
03/22/19
03/22
10:17
03/22/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
03/22/19
03/22
10:16
03/22/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.